Home/Filings/4/0001628908-25-000026
4//SEC Filing

Weinberg Jonathan 4

Accession 0001628908-25-000026

CIK 0001628908other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 6:15 PM ET

Size

10.3 KB

Accession

0001628908-25-000026

Insider Transaction Report

Form 4
Period: 2025-03-01
Weinberg Jonathan
General Counsel
Transactions
  • Tax Payment

    Class A Common Stock

    2025-03-01$8.99/sh8,808$79,184158,219 total
  • Award

    Class A Common Stock

    2025-03-03+65,470223,689 total
  • Award

    Class A Common Stock

    2025-03-03+10,640234,329 total
  • Tax Payment

    Class A Common Stock

    2025-03-03$8.77/sh3,544$31,081230,785 total
Footnotes (6)
  • [F1]This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.
  • [F2]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
  • [F3]Represents restricted stock units granted to Mr. Weinberg pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
  • [F4]Securities vest at a rate of 34% on March 3, 2026, and 33% on March 3, 2027, and March 3, 2028.
  • [F5]Represents the number of shares received upon the settlement of the performance-based share units (PSUs) awarded to the reporting person on March 1, 2022, following the certification of achievement of specified performance metrics by the Compensation Committee of the Company's Board of Directors on March 3, 2025. The shares underlying the PSU award vested at the conclusion of the performance period on December 31, 2024.
  • [F6]This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon settlement of performance-based share units.

Issuer

Evolent Health, Inc.

CIK 0001628908

Entity typeother

Related Parties

1
  • filerCIK 0001642833

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:15 PM ET
Size
10.3 KB